Point in Medical Technology
Navigation Links
Point in Medical Technology
... controlled ADHD symptoms from the
first time point measured (1.5 hours) through the last time point assessed
(13 hours) post-dose. Findings from this ... medication and continued
to do so for each time point measured throughout the 13-hour treatment ...
... middle dose performed best on both measures (0.5 point improvement, ADCS-CGIC and 0.9 point improvement, MMSE). Donepezil also showed an improvement on ADCS-CGIC (0.2 point improvement) and the MMSE ...
... a result of increased ability to document at the point of care; increased clinician productivity due ... one minute when nurses used the Motion C5 MCA for point of care documentation. -- Workflow ... able to transcribe in real-time closer to the point of care, increasing the likelihood for ...
... Water bearers from Fort point Channel to the Cyclorama mark 16th Annual 24-hour ... and copper buckets filled with water from Fort point Channel in South Boston into The Boston ... 1, people will make short processions to Fort point Channel and back to the Boston Center for ...
... biologic failure patients and rose unaccountably between week 6 (at which point the reported response rates between R788 and placebo were significantly ... inhibitor designed to interrupt the cellular signaling at the trigger point of inflammation, thereby stopping the progression of the disease. In July ...
... announced today that it has achieved the seventy-five percent enrollment point of its pivotal Phase III clinical trial treating metastatic cutaneous and ... Officer of Delcath, stated, "Reaching the seventy-five percent enrollment point represents a significant milestone for our Company as we continue to ...
... Status Scale (EDSS) sustained for at least three months (or at least a 1.5 point increase if baseline EDSS was 0; or 0.5 point increase if baseline EDSS was 5.0 and above). Sustained and ...
... analysis plan, the 5 mg dose was not statistically tested at any time point other than 2-hours post-dosing. The duration of the clinical ... believes approximately 90% of these patients experience agitation at some point during their lifetime, and more than two-thirds of this group will suffer ...
... we will be able to curtail spending on the program at a much earlier point in time, saving precious financial resources." The interim analysis will ... futility as well as safety. This constitutes a "go, no-go" decision point for the Viprinex clinical program. Passing the futility analysis would ...
... as a statistically significant, clinically relevant improvement of 1.9 point change from baseline levels compared to a 0.7 point worsening in the placebo group (a delta in NIS-LL of 2.6, p=0.043). In ...
... Is Changing the Management of Breast & Ovarian Cancer To register, point your browser here ... of Life Sciences Arizona State University. Registration To register, point your browser here ...
... management solution from Omnicell that provides hospitals with a single point of access for all patient medications that is simpler and safer than ... pharmacy to nursing unit and bedside dispensing cabinet systems. From the point at which a medication arrives at the receiving dock to the time it ...
... significant differences from placebo in this measure at the 2-hour time point with 30% of patients achieving pain-free status at the 2.5 mg dose (p = ... in which a patient reports a pain-free score at the 2-hour post-dose time point and remains pain-free for the remainder of the study period (up to 24 ...
... recommended nine hours, efficacy has been demonstrated from the first time point measured (two hours) through the 12-hour time point. Because DAYTRANA is a ... U.S. children aged 4 to 17 years, have been diagnosed with ADHD at some point in their lives, according to the U.S. Centers for Disease Control and ...
... was felt to be drug related. The Company saw no medical need, at this point in development, to take Study 101 to the point of organ toxicity because single doses of 40 mg/m2 are well above the ...
... treatment * Rotigotine treatment led to a 4.3 plus or minus 3.3 point increase in "sleep satisfaction" (RLS-6 Item 1) and a 4.9 plus or minus 3.0 point reduction of symptom severity "during the night" (RLS-6 Item 3) * ...
... was defined as an increase in a patient's EDSS score by at least one point that was confirmed after six months. A confirmed increase by one point in the EDSS scale can be an important and robust predictor of permanent ...
... funding for translational (bench-to-bedside) medical research, making CTMM one of the largest public-private partnerships in the world. This pivotal point in the organisation's development firmly positions the Netherlands as one of the world's leading destinations for translational biomedical research. ...
... HRT could be at an increased risk for breast cancer and that the overall health risks of this therapy could outweigh the possible benefits. From that point on, HRT was prescribed more conservatively with lower dosing options and individualization based on each woman's own health history. Since ...
... approximately 7.8 percent of all school-aged children, or about 4.4 million children aged 4 to 17 years, have been diagnosed with ADHD at some point in their lives, according to the Centers for Disease Control and Prevention (CDC).(14) The disorder is also estimated to affect 4.4 percent of US ...
... and active-controlled Phase 3 study that evaluated 3,397 healthy, postmenopausal women with an intact uterus aged 40 to 75 years. The primary end point of the SMART-1 trial was incidence of endometrial hyperplasia at one year. Secondary end points included bone mineral density (BMD) at two years, ...
... may cause these views, expectations and beliefs to change. However, while Idenix may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to do so. ...
... and not increase their VIRAMUNE dose to twice a day. The total duration of the once-daily lead-in dosing period should not exceed 28 days, at which point an alternative regimen may need to be started. Other side effects that patients have experienced include nausea, fatigue, fever, headache, ...
... power output at the onset of neuromuscular fatigue by an average of 20% and improve physical performance by helping athletes push past their normal point of exhaustion. This product is designed to increase nitric oxide levels in the body causing a hemodilation effect which expands blood vessels, ...
... middle dose performed best on both measures (0.5 point improvement, ADCS-CGIC and 0.9 point improvement, MMSE). Donepezil also showed an improvement on ADCS-CGIC (0.2 point improvement) and the MMSE ...
... a result of increased ability to document at the point of care; increased clinician productivity due ... one minute when nurses used the Motion C5 MCA for point of care documentation. -- Workflow ... able to transcribe in real-time closer to the point of care, increasing the likelihood for ...
... Water bearers from Fort point Channel to the Cyclorama mark 16th Annual 24-hour ... and copper buckets filled with water from Fort point Channel in South Boston into The Boston ... 1, people will make short processions to Fort point Channel and back to the Boston Center for ...
Two Point of Care Tests From Quest Diagnostics Receive FDA 510(k) Clearance
... have received FDA 510(k) clearance for two new point of care tests. The HemoCue(R) White Blood Cell ... that underscore the growing importance of point of care tests as complements to laboratory-based ... counts, the HemoCue WBC Analyzer is the first point of care device to produce quantitative results of ...... biologic failure patients and rose unaccountably between week 6 (at which point the reported response rates between R788 and placebo were significantly ... inhibitor designed to interrupt the cellular signaling at the trigger point of inflammation, thereby stopping the progression of the disease. In July ...
Leading Experts Endorse Bioheart's Muscle Stem Cell MyoCell Therapy
... is one stage of the broader MARVEL program, will meet a key efficacy end point - the six-minute walk." Dr. Carl Pepine, MD, Professor of Medicine, ... in Europe to date and added that "the myoblast therapy is at this time point the only stem cell therapy that is making the claim to actually induce ...... announced today that it has achieved the seventy-five percent enrollment point of its pivotal Phase III clinical trial treating metastatic cutaneous and ... Officer of Delcath, stated, "Reaching the seventy-five percent enrollment point represents a significant milestone for our Company as we continue to ...
... Status Scale (EDSS) sustained for at least three months (or at least a 1.5 point increase if baseline EDSS was 0; or 0.5 point increase if baseline EDSS was 5.0 and above). Sustained and ...
Acanya(TM) Gel, a New Treatment for Moderate to Severe Acne, Launched by Coria Laboratories
... acne. In addition, high levels of patient satisfaction with Acanya Gel point to the potential for increased patient adherence to treatment, and thus, ... 40 to 50 million Americans, or about 85 percent of people, at some point in their lives. The disorder is thought to be caused by multiple factors. ...... analysis plan, the 5 mg dose was not statistically tested at any time point other than 2-hours post-dosing. The duration of the clinical ... believes approximately 90% of these patients experience agitation at some point during their lifetime, and more than two-thirds of this group will suffer ...
St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse
... then subsequently emerges as basis for relapse." "The second key point is that we have found a large number of new genetic alterations that had ... treatments for ALL relapse. "But, this is a very important starting point because we have identified several key pathways that are the most common ...Technique for Rapidly Reprogramming Adult Cells Into Stem Cells Published in PLoS Biology
... this rapid and new approach for making iPS cells occurs at the transition point between incomplete and complete reprogramming to pluripotency. Previous studies have indicated that progression through the transition point had been notoriously inefficient, but now via the use of chemical ...... we will be able to curtail spending on the program at a much earlier point in time, saving precious financial resources." The interim analysis will ... futility as well as safety. This constitutes a "go, no-go" decision point for the Viprinex clinical program. Passing the futility analysis would ...
Two New Alzheimer's Disease Studies Show Advances Against Different Treatment Targets
... prevention, it becomes necessary to identify patients at the earliest point in the disease. Mild Cognitive Impairment (MCI) is the term used to ... the Study is to follow healthy subjects over time to detect the earliest point of cognitive impairment. In 2004, the researchers recruited 1,786 people ...... as a statistically significant, clinically relevant improvement of 1.9 point change from baseline levels compared to a 0.7 point worsening in the placebo group (a delta in NIS-LL of 2.6, p=0.043). In ...
... Is Changing the Management of Breast & Ovarian Cancer To register, point your browser here ... of Life Sciences Arizona State University. Registration To register, point your browser here ...
... management solution from Omnicell that provides hospitals with a single point of access for all patient medications that is simpler and safer than ... pharmacy to nursing unit and bedside dispensing cabinet systems. From the point at which a medication arrives at the receiving dock to the time it ...
... significant differences from placebo in this measure at the 2-hour time point with 30% of patients achieving pain-free status at the 2.5 mg dose (p = ... in which a patient reports a pain-free score at the 2-hour post-dose time point and remains pain-free for the remainder of the study period (up to 24 ...
NxStage(R) to Recognize Several Key Milestones at American Society of Nephrology's Renal Week 2007
... these subjects will be provided at this year's conference. "Passing the point of 2007 patients in 2007 indicates the high level of support the end-stage ... while NxStage may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to do so, whether ...... recommended nine hours, efficacy has been demonstrated from the first time point measured (two hours) through the 12-hour time point. Because DAYTRANA is a ... U.S. children aged 4 to 17 years, have been diagnosed with ADHD at some point in their lives, according to the U.S. Centers for Disease Control and ...
... was felt to be drug related. The Company saw no medical need, at this point in development, to take Study 101 to the point of organ toxicity because single doses of 40 mg/m2 are well above the ...
... treatment * Rotigotine treatment led to a 4.3 plus or minus 3.3 point increase in "sleep satisfaction" (RLS-6 Item 1) and a 4.9 plus or minus 3.0 point reduction of symptom severity "during the night" (RLS-6 Item 3) * ...
... was defined as an increase in a patient's EDSS score by at least one point that was confirmed after six months. A confirmed increase by one point in the EDSS scale can be an important and robust predictor of permanent ...
... funding for translational (bench-to-bedside) medical research, making CTMM one of the largest public-private partnerships in the world. This pivotal point in the organisation's development firmly positions the Netherlands as one of the world's leading destinations for translational biomedical research. ...
Project Zero Delay Accelerates Drug's Path to Clinical Trial
... that we've cultivated through our strategic alliance," Bast said. The alliance agreement also includes a commitment to regular meetings, a point of contact to remove obstacles, support of collaborative projects and a commitment to accelerate drug development. "The next challenge," said ...... HRT could be at an increased risk for breast cancer and that the overall health risks of this therapy could outweigh the possible benefits. From that point on, HRT was prescribed more conservatively with lower dosing options and individualization based on each woman's own health history. Since ...
... approximately 7.8 percent of all school-aged children, or about 4.4 million children aged 4 to 17 years, have been diagnosed with ADHD at some point in their lives, according to the Centers for Disease Control and Prevention (CDC).(14) The disorder is also estimated to affect 4.4 percent of US ...
... and active-controlled Phase 3 study that evaluated 3,397 healthy, postmenopausal women with an intact uterus aged 40 to 75 years. The primary end point of the SMART-1 trial was incidence of endometrial hyperplasia at one year. Secondary end points included bone mineral density (BMD) at two years, ...
... may cause these views, expectations and beliefs to change. However, while Idenix may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to do so. ...
Teeth and Gums Also Benefit from the Healing Power of Aloe Vera
... oral microflora -- disease-causing bacteria -- in the mouth. The ability of aloe vera tooth gel to successfully perform that function has been a point of contention for some dental professionals. However, the study compared the germ-fighting ability of an aloe vera tooth gel to two commercially ...... and not increase their VIRAMUNE dose to twice a day. The total duration of the once-daily lead-in dosing period should not exceed 28 days, at which point an alternative regimen may need to be started. Other side effects that patients have experienced include nausea, fatigue, fever, headache, ...
Reliv International's GlucAffect(TM) Proven Effective in Clinical Study
... group achieved statistically significant lower blood sugar levels as well as significant weight loss compared to both their own baseline starting point and to the results of the people in the placebo group," said Dr. Carl Hastings, Reliv's vice chairman and chief scientific officer, who is a Ph.D. in ...... power output at the onset of neuromuscular fatigue by an average of 20% and improve physical performance by helping athletes push past their normal point of exhaustion. This product is designed to increase nitric oxide levels in the body causing a hemodilation effect which expands blood vessels, ...
Shoulder Surgery Doesn't Prevent Return to Sports
... with an age range from 47-93. Patients were followed for a minimum of one year. Researchers noted that activity modification until the six month point in the rehabilitation protected the shoulder against any consequence of sport, such as a deceleration injury when a golf club hits the ground or a ...Rigel's R788 Significantly Improves Rheumatoid Arthritis in Phase 2b Clinical Trial
... cartilage and bone. Rigel's R788 is a novel, orally available syk kinase inhibitor designed to interrupt the cellular signaling at the trigger point of inflammation, thereby stopping the progression of the disease. Conference Call and Webcast Information Rigel will host a conference ...Accumetrics, Inc. Announces GRAVITAS Trial 50 Percent Enrolled
... than 70 sites in the U.S. and Canada, with a total enrollment goal of approximately 2,800 patients. "We are thrilled to have reached the halfway point for enrollment in our GRAVITAS trial," said Jeff Dahlen, Ph.D, Vice President, Clinical and Regulatory Affairs of Accumetrics, Inc. "Once complete, ...Sanofi-aventis Stands Behind the Safety of Lantus(R)
... causal relationship between Lantus(R) (insulin glargine [rDNA] injection) use and the occurrence of malignancies, as the authors of the study point out. Clinical studies, which represent the gold standard of evidence, do not indicate an association between insulin glargine and cancer. ...New Therapy Found to Prevent Heart Failure
... Boston Scientific, the study's sponsor. The MADIT-CRT Executive Committee stopped the trial on June 22, 2009, when the trial achieved its primary end point - significant reduction in heart failure or death with CRT-D versus ICD-only. Cardiologist Arthur Moss, M.D., professor of Medicine at the ...Inspiration for 'My Sister's Keeper' Speaks Out
... in-depth coverage in nearly every major media outlet in the world. The coverage caught the eye of author Picoult, who used it as a jumping off point for her novel, My Sister's Keeper. "We stress to people that the book is fiction and that our family is reality," explains Jack Nash. "The ...Other ContentspleurapleurapointpointpointpointpointpointpointpointpointpointpolaritypolaritypolaritynucleinucleinucleinucleinucleinucleipolarpolarpolarpolarpolargraingraingraingraingraingrainOther TagsSpectroSpectroSpectroSpectroHoseHoseHose
(Date:11/24/2009)...tutes fish food is a matter of debate. A high-prof...almost 50 percent of their carbon from trees and l...terrestrial and aquatic ecosystems. , But new re...s is not likely to be true. Algae provide a much r...ing to research published this week in the Procee...
(Date:11/23/2009)...e, Mass. November 23, 2009 Applied mathematician...Hosta lancifolia ), a characteristic long leaf wit...ripples along the edges. The simple cause of the l...rom bending during differential growthwas revealed...foam ribbons. , Haiyi Liang, a postdoctoral stud...
(Date:11/23/2009)... Ill. A new study provides "incontrovertible evid...the island of Sumatra about 73,000 years ago defor... the epicenter, researchers report. , The volcan... into the atmosphere, leaving a crater (now the wo...s long and 35 kilometers wide. Ash from the event ...
Breaking Biology News(10 mins):Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3The cause behind the characteristic shape of a long leaf revealed 2Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2Universal Health Services Inc Announces Dividend 51192 1Data published in the New England Journal of Medicine support use of raxibacumab 28ABthrax 29 for the treatment of inhalation anthrax 9185 1Data published in the New England Journal of Medicine support use of raxibacumab 28ABthrax 29 for the treatment of inhalation anthrax 9185 2TeamPraxis Finishes Strong First Year of National Sales 51185 1TeamPraxis Finishes Strong First Year of National Sales 51185 2TeamPraxis Finishes Strong First Year of National Sales 51185 3TeamPraxis Finishes Strong First Year of National Sales 51185 4TeamPraxis Finishes Strong First Year of National Sales 51185 5(Date:11/27/2009)... , DALLAS, Nov. 27 ...l procedure only 25 years ago, solid organ transpl... thanks to the extraordinary men and women who gat.... 11. Leaders came together from medical centers a...of Baylor Regional Transplant Institute (BRTI), on...
(Date:11/27/2009)... , NEUILLY-SUR-SEINE, France, Nov. 27 /PRNew...an professional cycling team dedicated to ethical ...ling champions, announced today that it will becom...nsitions Optical as a new sponsor of the team. Tra...er of adaptive eyewear, offering the most advanced...
(Date:11/27/2009)...ng and cycling plus low-emission vehicles may redu... , FRIDAY, Nov. 27 (HealthDay News) -- Encourag...sing cars would offer much greater public health b...es, U.K. researchers have found. , The study co...ernative urban land transport scenarios for London...
(Date:11/27/2009)... Voyant Health™ announce...an) has licensed its TraumaCad Enterprise orthoped...rkflow solution. , (PRWEB...ced today that Spectrum Health (Grand Rapids, Mich...edic templating solution and its TraumaCad Extend ...
(Date:11/27/2009)... Three new interactive anatomy...ams & Wilkins expand health sciences learning ... Durham, NC (Vocus) November 27, 2...mp; Wilkins (LWW), a division of Wolters Kluwer He...w anatomy education apps on the App Store. Clement...
Breaking Medicine News(10 mins):Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 3Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5[0] Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary[0] Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor[0] More Foot Power, Less Car Pollution Best for Health[0] Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend[0] Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store
ABS2000ProVueVNUSXPSSpectroSkinSkanSpectrofluorophotometerMiniFluoBTF111CionniCLKSorterHoseUnderbody
Other Tagsmeters 2meters 3readings 2readings 3monkey 2transplantation 2transplantation 3transplantation 4influenza 2influenza 3influenza 4influenza 5influenza 6blueprint 2blueprint 3computers 2computers 3
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |